Literature DB >> 29362566

Occipitocervical Hemolymphangioma in an Adult with Neck Pain and Stiffness: Case Report and Literature Review.

Yongchao Li1,2, Xing Zhang1, Xiaodong Pang2, Liang Yang2, Baogan Peng2.   

Abstract

INTRODUCTION: Hemolymphangioma is an extremely rare malformation of the lymphatic and blood vessels. A limited number of hemolymphangioma cases occurring in the pancreas, extremities, spleen, and other organs have been reported until September 2017. To the best of our knowledge, no cases of hemolymphangioma in the occipitocervical region have been reported in the literature. CASE
PRESENTATION: We reported the case of a 23-year-old male patient with an occipitocervical lesion presenting atypically as neck pain and stiffness over a period of five months. Although hemolymphangioma has historically demonstrated a female predilection (2.25 : 1 female to male) and presentation in the third to fourth decades of life, this case is an atypical manifestation occurring in a young male patient. The clinical characteristics and management choices of this uncommon case of hemolymphangioma in the occipitocervical region are discussed, and a review based on the available literature is also presented.
CONCLUSION: Hemolymphangioma of the occipitocervical region is an uncommon presentation of a rare lesion. Although rare, hemolymphangioma should be considered a differential diagnosis for masses occurring in the occipitocervical region. Complete surgical resection is the treatment of choice and affords a good prognosis.

Entities:  

Year:  2017        PMID: 29362566      PMCID: PMC5738575          DOI: 10.1155/2017/7317289

Source DB:  PubMed          Journal:  Case Rep Med


1. Introduction

Hemolymphangioma is a malformation of both the lymphatic and vascular systems. Clinically, the onset of hemolymphangioma can vary from a slowly growing cyst over a period of years to an aggressive enlarging tumor, without invasive ability [1]. A limited number of hemolymphangioma cases occurring in the pancreas, extremities, spleen, and other organs have been reported until September 2017 [1-25]. To the best of our knowledge, the present study describes the first case of hemolymphangioma in the occipitocervical region, which appears to be a rare site of presentation of a rare neoplasm and reviews the clinical characteristics and management choices of this condition based on the existing available literature.

2. Case Presentation

A 23-year-old man presented with a posterior occipitocervical subcutaneous mass that had been present since birth and had been growing for years. He complained of neck pain and stiffness for approximately 5 months, with no symptoms of extremity numbness or pain. There was no history of trauma or weight loss and was no family history of cancer. Physical examination revealed a partially spherical lesion, compressible, with mild tenderness. Laboratory data showed no infectious or inflammatory findings. Magnetic resonance imaging (MRI) examination was performed preoperatively, in order to establish the extent of the tumor and define its association with the surrounding tissues. The occipitocervical MRI scan (Figure 1) showed an approximate lesion measuring 11.2 × 3.5 × 6.9 cm with an irregular shape, unclear boundary, and uneven signal intensity on sagittal T2-weighted imaging (WI), dominantly high signal intensity on T2-WI fat suppressed, and markedly heterogeneous enhancement on coronal enhanced scan in the occipitocervical subcutaneous tissue.
Figure 1

MRI demonstrated a mass (arrows) in the occipitocervical subcutaneous tissue with uneven signal intensity on (Figure 1(a)) sagittal T2-weighted, (Figure 1(b)) T2-weighted fat suppressed, and (Figure 1(c)) coronal enhanced images.

The patient was admitted for surgery. During the operation, the boundary of the mass was unclear. Macroscopically, the mass spaces between all mass measurements were 10.8 × 3.4 × 6.2 cm. It was polycystic and soft in consistency. Histopathological examination (Figure 2) revealed abnormal lymphatic and blood vessels with polycystic spaces, thin wall, and dyed red lymph and blood cells within the lumen, which confirmed a diagnosis of hemolymphangioma. The postoperative course of the patient was uneventful, and the patient was discharged 2 weeks following the surgery. At 8 months of follow-up, he had no visible recurrence of the subcutaneous lesion and no evidence of neck pain and stiffness.
Figure 2

Histological analysis of specimen (hematoxylin and eosin stain; magnification ×100) showed abnormal lymphatic (black arrowheads) and blood vessels (black stars) with polycystic spaces.

3. Literature Review

In preparation of this case report, a review of the existing medical literature was performed with the PubMed database, using the following keyword: “Hemolymphangioma” to identify all possible studies published up to September 2017. References from these articles were also reviewed. After carefully reviewing and summarizing each published article, we selected 25 original studies with 26 case reports [1-25]. We find this tumor typically appearing in adult patients ranging in age from 2 months to 62 years, with an average age of 31.4 years. Nearly 61.5% (16/26) of all cases occurred in patients over the age of 20. Hemolymphangioma is most common in female patients, with the sex distribution of male to female 1 : 2.25. The clinical manifestation is not typical, whereby it can be hidden for a long time. The reported anatomic location of hemolymphangioma has been 23.1% (6/26) in the pancreas, 15.3% (4/26) in the extremities, 11.5% (3/26) in the spleen, and almost 69.2% (18/26) in internal or visceral locations. To date, no reports documenting recurrence have been reported after short-term follow-up. The clinical characteristics and management choices of all 26 patients with hemolymphangioma are shown in Table 1.
Table 1

The clinical characteristics and management choices of 26 patients with hemolymphangioma [1–25].

CasePublication yearAge (y)/sexLocalizationSize (cm)Chief complaintTreatmentFollow-up (months)RecurrenceEvolution
1 [8]197920/FLower extremityNAPainful swelling, chest pain, and pulmonary embolismUrokinase for a short period; prolonged maintenance therapy was with a low dose of heparinNANAFavourable
2 [9]19881.5/FLower extremity4.0 × 5.0Not reportedPressure dressing and combined compression therapy9Not reportedFavourable
3 [13]1993NA/MAbdomen13.0Not reportedAutopsyNANAStillborn
4 [14]19962/FEsophagus9.5 × 2.5 × 2.0Acute dyspneaEndoscopically7Not reportedFavourable
5 [2]200353/FPancreas4.0 × 3.0Abdominal pain and weight lossPancreatoduodenectomyNANAFavourable
6 [23]200515/FTongueNAPain and bleedingPulsed-dye laser10Not reportedFavourable
7 [3]200853/MPancreasNASevere anemia due to gastrointestinal bleedingPylorous-preserving pancreatoduodenectomyNANot reportedFavourable
8 [4]200920/FPancreas18.0 × 16.0 × 12.5Epigastric discomfortPancreatoduodenectomy26Not reportedFavourable
9 [1]20100.16/FLower extremity4.5AsymptomaticSurgical excision12Not reportedFavourable
10 [1]20105/MLower extremity2.1 × 1.8 × 0.5AsymptomaticSurgical excision12Not reportedFavourable
11 [15]201257/FChest wall9.0 × 9.0 × 5.0Chest tightness, shortness of breath, cough, and expectorationThoracotomy3Not reportedFavourable
12 [16]201257/FSmall intestine5.0 × 4.0Recurrent melenaPartial resection of the small intestine12Not reportedFavourable
13 [17]201353/FStomach1.5Bloody vomiting and epigastric painEndoscopic therapyNANAFavourable
14 [18]201337/MRectum20.0 × 8.0 × 8.0Rectal bleeding and tenesmusLow anterior resection of the rectosigmoid colon with handsewn transanal coloanal anastomosis12Not reportedFavourable
15 [5]201339/FPancreas10.0 × 7.0Abdominal painPancreatic body-tail resection combined with splenectomyNANot reportedFavourable
16 [19]201424/FDuodenum4.0 × 1.5Severe anemiaSurgical excisionNANot reportedFavourable
17 [6]201452/FPancreas8.0 × 6.5 × 6.0Abdominal pain and epigastric discomfortPylorus preserving pancreatoduodenectomyNANADied
18 [10]201412/MSpleen15.7 × 8.5Abdominal painLaparoscopic partial splenectomy12Not reportedFavourable
19 [7]201557/FPancreas8.0 × 6.0 × 4.5Epigastric discomfortSurgical excision2Not reportedFavourable
20 [11]201562/FSpleen11.0 × 6.0 × 3.0Abdominal painTotal splenectomy12Not reportedFavourable
21 [20]201517/MWaist12.0 × 6.0 × 6.0Back painSurgical excision7Not reportedFavourable
22 [12]201525/FSpleen, retroperitoneum28.0 × 24.0 × 15.0Progressive splenomegalySplenectomyNANAFavourable
23 [21]201515/FParaspinousNAScoliosisPosterior spinal fusion12Not reportedFavourable
24 [22]201648/FPosterior mediastinum3.1 × 2.4Shortness of breath and chest tightnessThoracic surgery12Not reportedFavourable
25 [24]20163/MGreater omentum20 × 15 × 6Abdominal painSurgical excision6Not reportedFavourable
26 [25]201757/MRectum, sigmoid25RectorrhagiaSurgical excision6Not reportedFavourable

NA, the data were not available.

4. Discussion

Hemolymphangioma is thought to originate from the mesenchymal tissue [15] and typically found by palpation or with symptomatic compression of nearby anatomic structures [21]. It may be divided into primary and secondary lymphatic vascular tumors. The primary tumor is considered to be a congenital malformation of the lymphatic vascular system, possibly formed due to obstruction of the venolymphatic communication between dysembryoplastic vascular tissue and the systemic circulation. By contrast, the secondary tumor is caused by poor lymph drainage and lymphatic damage resulting from surgery or trauma [15, 20]. This tumor is a benign hamartoma of blood and lymphatic vessels with a predilection for the pancreas, spleen, and lower extremity and, less commonly, in occipitocervical lesion. In general, hemolymphangiomas are large masses of varying sized cystic cavities with thin walls, having multiple thin septa and containing fluid similar to hemorrhagic fluid, and rarely of clear lymphatic nature. The tumor size varies due to the anatomical location and relationship to the neighboring tissues [15]. The majority of small tumors remain asymptomatic for a long period of time. As the tumor develops, discomfort occurs, which is mainly caused by surrounding or infiltrating the neighboring tissues or other major structures [15]. In the current case, the main complaints were neck pain and stiffness for approximately five months, without symptoms of extremity numbness or pain. In clinical examinations, they are usually described as soft and compressible masses, loculated in pattern [20]. The histopathological examination suggests that the tumors often consist of abnormal lymphatic and blood vessels with polycystic spaces, and the thin-walled cystic lesion has connective septa covered by endothelium [7]. However, all cases in the literature had no abnormal laboratory findings as did our patient. The impossibility to preoperatively define the histological type of the tumor explains the difficulties to reach a correct differential diagnosis. Biopsy should not be performed because of the high risk of massive bleeding. It is very important and crucial for radiologists to recognize these lesions and establish an accurate diagnosis so as to avoid a biopsy, which could cause severe hemorrhage [6]. In the present study, an occipitocervical MRI showed a lesion with irregular shape, unclear boundary, and uneven signal intensity on sagittal T2-WI, dominantly high signal intensity on T2-WI fat suppressed, and markedly heterogeneous enhancement on coronal enhanced scan in the occipitocervical subcutaneous tissue. These observations may indicate the presence of a lower number of tortuous blood vessels and water-based substance in the lesion, which was then confirmed during surgery. Imaging examinations, including ultrasound, computed tomography, and MRI scans, are useful in order to confirm the diagnosis, identify the tumor nature, and observe its extension and association with the surrounding tissues, assisting the selection of the surgical strategy [20]. However, an accurate diagnosis of the tumor cannot be preoperatively established in spite of modern imaging techniques and can be postoperatively based on histological evidence. Most researchers believe that hemolymphangioma is commonly a benign disease and has no invasive ability [1, 2, 5–11, 13–23]. But some studies recently found that it can invade the adjacent structures [3, 4, 12]. Toyoki et al. discovered that the tumor from pancreas invaded to the duodenum to cause the duodenal bleeding [3]. In 2009, Sun and colleagues reported that the giant tumor originated in pancreas, infiltrated the transverse mesocolon and greater omentum, and tightly adhered to duodenum and superior mesenteric artery [4]. Recently, Zhang et al. found multiple hemolymphangioma of the visceral organs and reported the retroperitoneal tumor extending to the left colon and small bowel mesentery [12]. The optimal treatment strategy for this lesion remains controversial. Surgical resection appears to be the most effective treatment for hemolymphangioma, especially when the tumor increases in size and creates pressure on the surrounding tissues. To prevent recurrence, during surgery, a thorough radical resection may be necessary. Furthermore, with tumor adhesion or invasion to the surrounding organs, the removal of adjacent organs needs to be considered [3]. Tumor removal may also be associated with complications such as infection, fistula, and hemorrhage [4, 16]. Beninson et al. successfully treated hemolymphangioma in a neonate using a pressure dressing initially followed by combined compression therapy [9]. Wang and colleagues reported a case of successful treatment of hemolymphangioma of the tongue with a variable-pulse 595 nm pulsed-dye laser [23]. All cases in the existing literature had good clinical outcomes as did our case. The risk of recurrence seems very low, and no documented reports of recurrence have been reported in the literature. In addition, so far, no case of malignant transformation was reported. However, careful follow-up with MRI or ultrasound is recommended.

5. Conclusion

Hemolymphangioma of the occipitocervical region is an uncommon presentation of a rare lesion. Although rare, hemolymphangioma should be considered a differential diagnosis for masses occurring in the occipitocervical region. Complete surgical resection is the treatment of choice and affords a good prognosis.
  25 in total

Review 1.  Hemolymphangioma of the pancreas: case report and review of the literature.

Authors:  Domingo C Balderramo; Cecilia Di Tada; Ana B de Ditter; Juan C Mondino
Journal:  Pancreas       Date:  2003-08       Impact factor: 3.327

2.  Hemolymphangioma: a rare differential diagnosis of cystic-solid or cystic tumors of the pancreas.

Authors:  Fei Dong; Yi Zheng; Jian-Jun Wu; Yan-Biao Fu; Kai Jin; Ming Chao
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

3.  Paraspinous hemolymphangioma associated with adolescent scoliosis.

Authors:  Ishaan Swarup; Benjamin T Bjerke-Kroll; Matthew E Cunningham
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

4.  Hemolymphangioma in a neonate--a therapeutic problem--case history.

Authors:  J Beninson; J P Hurley
Journal:  Angiology       Date:  1988-12       Impact factor: 3.619

5.  Hemolymphangioma of the chest wall: A rare case report.

Authors:  Xiaona Zhang; Xinxiu Sheng; Feiye Liu; Ruan Jian; Libo Li; Rongcheng Luo
Journal:  Oncol Lett       Date:  2012-02-02       Impact factor: 2.967

Review 6.  A case of invasive hemolymphangioma of the pancreas.

Authors:  Yoshikazu Toyoki; Kenichi Hakamada; Shunji Narumi; Masaki Nara; Daisuke Kudoh; Keinosuke Ishido; Mutsuo Sasaki
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 7.  Hemolymphangioma in the posterior mediastinum: a case report and literature review.

Authors:  Jinxiang Wu; Hong Shangguan; Shengyu Zhou; Liang Dong
Journal:  Clin Respir J       Date:  2016-05-02       Impact factor: 2.570

8.  Multiple Hemolymphangioma of the Visceral Organs: A Case Report and Review of the Literature.

Authors:  Deng-Yong Zhang; Zheng Lu; Xiang Ma; Qiu-Yue Wang; Wang-Liang Sun; Wei Wu; Pei-Yuan Cui
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

9.  Treatment of hemolymphangioma of the spleen by laparoscopic partial splenectomy: a case report.

Authors:  Yue Zhang; Xue-Min Chen; Dong-Lin Sun; Chun Yang
Journal:  World J Surg Oncol       Date:  2014-03-21       Impact factor: 2.754

10.  Hemolymphangioma of Greater Omentum: A Rare Case Report.

Authors:  Sagar Pandey; Miao Fan; Dandan Chang; Junfeng Zhu; Ying Zhu; Ziping Li
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

View more
  1 in total

1.  A rare case of retroperitoneal hemolymphangioma.

Authors:  Manato Ohsawa; Toshihiko Kohashi; Jun Hihara; Hidenori Mukaida; Mayumi Kaneko; Naoki Hirabayashi
Journal:  Int J Surg Case Rep       Date:  2018-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.